Tuberculosis Vaccines: Hopes and Hurdles

ISSN: 2212-3989 (Online)
ISSN: 1871-5265 (Print)

Volume 15, 3 Issues, 2015

Download PDF Flyer

Infectious Disorders - Drug Targets

Formerly: Current Drug Targets - Infectious Disorders

Aims & ScopeAbstracted/Indexed in

Submit Abstracts Online Submit Manuscripts Online

Jean-Marc Sabatier
Laboratoire ERT 62 'Ingénierie des peptides à visée thérapeutique'
Université de la Méditerranée
Faculté de Médecine Nord
Boulevard Pierre Dramard
13916 - MARSEILLE, Cedex 20

View Full Editorial Board

Subscribe Purchase Articles Order Reprints

Tuberculosis Vaccines: Hopes and Hurdles

Infectious Disorders - Drug Targets, 13(5): 318-321.

Author(s): Mohamed J. Ahsan, Shiv K. Garg, Bharat Vashistha and Piush Sharma.

Affiliation: Maharishi Arvind College of Pharmacy, Jaipur, Rajasthan 302 023, India.


Tuberculosis (TB) remains as one of the most serious public health problems worldwide. It is one of the main causes of death in poor and developing countries, especially in sub-Saharan Africa, where it may be associated with the human immunodeficiency virus (HIV). It has been estimated that one third of the world population is infected by Mycobacterium tuberculosis (Mtb), and there were about 8.7 million new TB cases, and about 1.4 million yearly deaths due to TB in 2011. DOTS is the currently used drug therapy in TB but there is non-compliance which results in emergence of resistance. Bacille Calmette Guérin (BCG), an attenuated vaccine derived from Mycobacterium bovis, is the only licensed TB vaccine, but not recommended in HIV-infected infants. There are 14 vaccine candidates that have entered clinical trials and over 35 candidates in discovery and preclinical development. Mycobacterium indicus pranii [Mw; MIP] and M. vaccae are in phase III clinical trial and the Drug Controller of India licensed MIP for human use in India.


Clinical trials, review, tuberculosis, tuberculosis vaccines.

Purchase Online Order Reprints Order Eprints Rights and Permissions

Article Details

Volume: 13
Issue Number: 5
First Page: 318
Last Page: 321
Page Count: 4
DOI: 10.2174/1871526513666131201125513

Related Journals

Webmaster Contact: Copyright © 2015 Bentham Science